AAPL312.66+4.03 (+1.31%) ▲|ABBV254.76-6.31 (-2.42%) ▼|ABT95.63+0.23 (+0.24%) ▲|ACN136.96-0.39 (-0.28%) ▼|ADBE218.07-1.65 (-0.75%) ▼|AMAT592.79-10.25 (-1.70%) ▼|AMD552.05+34.23 (+6.61%) ▲|AMGN366.44-7.71 (-2.06%) ▼|AMT162.11-3.92 (-2.36%) ▼|AMZN244.16+1.49 (+0.61%) ▲|AVGO373.90+13.45 (+3.73%) ▲|AXP356.03+4.07 (+1.16%) ▲|BA234.54+8.05 (+3.55%) ▲|BAC59.90+1.17 (+1.99%) ▲|BKNG181.03-3.53 (-1.91%) ▼|BLK1,011.21+15.48 (+1.55%) ▲|BMY56.70-1.43 (-2.46%) ▼|BNY149.96+3.34 (+2.28%) ▲|BRK-B506.58-1.20 (-0.24%) ▼|C143.86+3.89 (+2.78%) ▲|CAT969.92+6.39 (+0.66%) ▲|CL93.39-1.74 (-1.83%) ▼|CMCSA23.38-0.41 (-1.72%) ▼|COF206.50+1.38 (+0.67%) ▲|COP103.58-1.15 (-1.10%) ▼|COST950.25-1.42 (-0.15%) ▼|CRM165.65-0.46 (-0.28%) ▼|CSCO113.98+1.29 (+1.14%) ▲|CVS102.08-2.64 (-2.52%) ▼|CVX168.10-1.10 (-0.65%) ▼|DE635.24+13.97 (+2.25%) ▲|DHR193.62-4.31 (-2.18%) ▼|DIS97.41-2.09 (-2.10%) ▼|DUK125.97-3.63 (-2.80%) ▼|EMR141.56+2.51 (+1.81%) ▲|FDX309.93-3.07 (-0.98%) ▼|GD376.88+3.34 (+0.89%) ▲|GE378.68+1.63 (+0.43%) ▲|GEV1,152.04+38.93 (+3.50%) ▲|GILD129.61-1.66 (-1.26%) ▼|GM77.85+1.85 (+2.43%) ▲|GOOG364.90+8.72 (+2.45%) ▲|GOOGL366.46+6.55 (+1.82%) ▲|GS1,055.29+34.29 (+3.36%) ▲|HD350.65-7.25 (-2.03%) ▼|HON231.18+1.32 (+0.57%) ▲|IBM299.52+10.00 (+3.45%) ▲|INTC122.20+1.85 (+1.54%) ▲|INTU272.14-3.21 (-1.17%) ▼|ISRG432.83+6.82 (+1.60%) ▲|JNJ259.33-3.71 (-1.41%) ▼|JPM337.72+4.75 (+1.43%) ▲|KO82.96-1.18 (-1.40%) ▼|LIN540.52-6.12 (-1.12%) ▼|LLY1,200.06-13.85 (-1.14%) ▼|LMT538.00-7.91 (-1.45%) ▼|LOW223.78-3.72 (-1.64%) ▼|LRCX350.20-1.21 (-0.34%) ▼|MA533.10-6.29 (-1.17%) ▼|MCD279.50-1.13 (-0.40%) ▼|MDLZ59.17-1.74 (-2.86%) ▼|MDT83.06-0.13 (-0.16%) ▼|META600.29+17.39 (+2.98%) ▲|MMM159.15-1.29 (-0.80%) ▼|MO71.88-0.83 (-1.14%) ▼|MRK126.78-2.78 (-2.15%) ▼|MS222.10+8.17 (+3.82%) ▲|MSFT386.74-3.75 (-0.96%) ▼|MU984.75+9.19 (+0.94%) ▲|NEE87.44-0.90 (-1.02%) ▼|NFLX76.02-1.63 (-2.10%) ▼|NKE43.34-0.75 (-1.70%) ▼|NOW107.93+1.61 (+1.51%) ▲|NVDA195.55+0.72 (+0.37%) ▲|ORCL143.76+3.49 (+2.49%) ▲|PEP143.29-0.93 (-0.64%) ▼|PFE23.72-0.60 (-2.47%) ▼|PG149.31-2.10 (-1.39%) ▼|PLTR132.54+3.24 (+2.51%) ▲|PM184.76+2.49 (+1.37%) ▲|QCOM186.48+10.23 (+5.80%) ▲|RTX201.37+2.12 (+1.06%) ▲|SBUX102.11-2.16 (-2.07%) ▼|SCHW100.62+3.62 (+3.73%) ▲|SO95.99-1.99 (-2.03%) ▼|SPG225.00-1.06 (-0.47%) ▼|T20.58+0.00 (+0.00%) ▲|TMO517.60-5.84 (-1.12%) ▼|TMUS181.79+4.27 (+2.41%) ▲|TSLA419.77+26.32 (+6.69%) ▲|TXN303.50+10.42 (+3.56%) ▲|UBER72.42-2.01 (-2.70%) ▼|UNH417.99-7.37 (-1.73%) ▼|UNP282.59+0.34 (+0.12%) ▲|UPS110.02-0.64 (-0.58%) ▼|USB62.83+1.10 (+1.78%) ▲|V357.25-4.88 (-1.35%) ▼|VZ42.07-0.49 (-1.15%) ▼|WFC87.45+1.94 (+2.27%) ▲|WMT110.65-1.19 (-1.06%) ▼|XOM136.44-0.65 (-0.47%) ▼|AAPL312.66+4.03 (+1.31%) ▲|ABBV254.76-6.31 (-2.42%) ▼|ABT95.63+0.23 (+0.24%) ▲|ACN136.96-0.39 (-0.28%) ▼|ADBE218.07-1.65 (-0.75%) ▼|AMAT592.79-10.25 (-1.70%) ▼|AMD552.05+34.23 (+6.61%) ▲|AMGN366.44-7.71 (-2.06%) ▼|AMT162.11-3.92 (-2.36%) ▼|AMZN244.16+1.49 (+0.61%) ▲|AVGO373.90+13.45 (+3.73%) ▲|AXP356.03+4.07 (+1.16%) ▲|BA234.54+8.05 (+3.55%) ▲|BAC59.90+1.17 (+1.99%) ▲|BKNG181.03-3.53 (-1.91%) ▼|BLK1,011.21+15.48 (+1.55%) ▲|BMY56.70-1.43 (-2.46%) ▼|BNY149.96+3.34 (+2.28%) ▲|BRK-B506.58-1.20 (-0.24%) ▼|C143.86+3.89 (+2.78%) ▲|CAT969.92+6.39 (+0.66%) ▲|CL93.39-1.74 (-1.83%) ▼|CMCSA23.38-0.41 (-1.72%) ▼|COF206.50+1.38 (+0.67%) ▲|COP103.58-1.15 (-1.10%) ▼|COST950.25-1.42 (-0.15%) ▼|CRM165.65-0.46 (-0.28%) ▼|CSCO113.98+1.29 (+1.14%) ▲|CVS102.08-2.64 (-2.52%) ▼|CVX168.10-1.10 (-0.65%) ▼|DE635.24+13.97 (+2.25%) ▲|DHR193.62-4.31 (-2.18%) ▼|DIS97.41-2.09 (-2.10%) ▼|DUK125.97-3.63 (-2.80%) ▼|EMR141.56+2.51 (+1.81%) ▲|FDX309.93-3.07 (-0.98%) ▼|GD376.88+3.34 (+0.89%) ▲|GE378.68+1.63 (+0.43%) ▲|GEV1,152.04+38.93 (+3.50%) ▲|GILD129.61-1.66 (-1.26%) ▼|GM77.85+1.85 (+2.43%) ▲|GOOG364.90+8.72 (+2.45%) ▲|GOOGL366.46+6.55 (+1.82%) ▲|GS1,055.29+34.29 (+3.36%) ▲|HD350.65-7.25 (-2.03%) ▼|HON231.18+1.32 (+0.57%) ▲|IBM299.52+10.00 (+3.45%) ▲|INTC122.20+1.85 (+1.54%) ▲|INTU272.14-3.21 (-1.17%) ▼|ISRG432.83+6.82 (+1.60%) ▲|JNJ259.33-3.71 (-1.41%) ▼|JPM337.72+4.75 (+1.43%) ▲|KO82.96-1.18 (-1.40%) ▼|LIN540.52-6.12 (-1.12%) ▼|LLY1,200.06-13.85 (-1.14%) ▼|LMT538.00-7.91 (-1.45%) ▼|LOW223.78-3.72 (-1.64%) ▼|LRCX350.20-1.21 (-0.34%) ▼|MA533.10-6.29 (-1.17%) ▼|MCD279.50-1.13 (-0.40%) ▼|MDLZ59.17-1.74 (-2.86%) ▼|MDT83.06-0.13 (-0.16%) ▼|META600.29+17.39 (+2.98%) ▲|MMM159.15-1.29 (-0.80%) ▼|MO71.88-0.83 (-1.14%) ▼|MRK126.78-2.78 (-2.15%) ▼|MS222.10+8.17 (+3.82%) ▲|MSFT386.74-3.75 (-0.96%) ▼|MU984.75+9.19 (+0.94%) ▲|NEE87.44-0.90 (-1.02%) ▼|NFLX76.02-1.63 (-2.10%) ▼|NKE43.34-0.75 (-1.70%) ▼|NOW107.93+1.61 (+1.51%) ▲|NVDA195.55+0.72 (+0.37%) ▲|ORCL143.76+3.49 (+2.49%) ▲|PEP143.29-0.93 (-0.64%) ▼|PFE23.72-0.60 (-2.47%) ▼|PG149.31-2.10 (-1.39%) ▼|PLTR132.54+3.24 (+2.51%) ▲|PM184.76+2.49 (+1.37%) ▲|QCOM186.48+10.23 (+5.80%) ▲|RTX201.37+2.12 (+1.06%) ▲|SBUX102.11-2.16 (-2.07%) ▼|SCHW100.62+3.62 (+3.73%) ▲|SO95.99-1.99 (-2.03%) ▼|SPG225.00-1.06 (-0.47%) ▼|T20.58+0.00 (+0.00%) ▲|TMO517.60-5.84 (-1.12%) ▼|TMUS181.79+4.27 (+2.41%) ▲|TSLA419.77+26.32 (+6.69%) ▲|TXN303.50+10.42 (+3.56%) ▲|UBER72.42-2.01 (-2.70%) ▼|UNH417.99-7.37 (-1.73%) ▼|UNP282.59+0.34 (+0.12%) ▲|UPS110.02-0.64 (-0.58%) ▼|USB62.83+1.10 (+1.78%) ▲|V357.25-4.88 (-1.35%) ▼|VZ42.07-0.49 (-1.15%) ▼|WFC87.45+1.94 (+2.27%) ▲|WMT110.65-1.19 (-1.06%) ▼|XOM136.44-0.65 (-0.47%) ▼|
19.4 C
New York
Monday, July 6, 2026

Tag: as

newssourceFORcompanyinformationcontent1releasesmarket

JEF INVESTIGATION: Robbins Geller Rudman & Dowd LLP Launches Investigation into Jefferies Financial Group, Inc. and Encourages Investors and Potential Witnesses to Contact Law...

We are investigating whether Jefferies Financial Group Inc. & certain of its top executives made materially false &/or misleading statements to investors.

Bishop’s University researcher co-edits new international volume on language and classroom equity

SHERBROOKE, QC, June 5, 2026 /CNW/ - Every classroom in Canada is already multilingual. A new Bloomsbury column co-edited by Dr. Sunny Man Chu Lau,...

InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering

New York, NY, June 05, 2026 (GLOBE NEWSWIRE) -- InterPrivate Investment Partners V, Inc. (the “Company”), a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, announced the closing of its initial public offering of 20,125,000 units, including 2,625,000 units issued pursuant to the exercise of the underwriters’ over-allotment option in full, at a price of $10.00 per unit on June 5, 2026. Total gross proceeds from the offering were $201.25 million before deducting underwriting discounts and commissions and other offering expenses payable by the Company.

Think Together Awards 2026 Beyond Think Together Scholarships to Ten High School Seniors Across the State

Each recipient received $3,000 to support their future higher education goals.SANTA ANA, Calif., June 5, 2026 /PRNewswire/ -- Think Together, California's largest nonprofit expanded...

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WGS

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 3, 2026.

Ractigen Therapeutics Announces ADA 2026 Late-Breaking Presentation Highlighting saRNA as a New Frontier in Obesity Control

Breakthrough preclinical data demonstrate that LiCO-saUcp1 effectively turns white fat into calorie-burning brown fat, driving massive fat loss while fully preserving lean muscle mass...

ELWT Investor News: If You Have Suffered Losses in Elauwit Connection, Inc. (NASDAQ: ELWT), You Are Encouraged to Contact The Rosen Law Firm About...

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) --

Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Elauwit Connection, Inc. (NASDAQ: ELWT) resulting from allegations that Elauwit may have issued materially misleading business information to the investing public.

Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules

$8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. (WGS)

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Connecticut on behalf of all persons or entities who purchased or otherwise acquired GeneDx Holdings Corp. (“WGS” or the “Company”) (NASDAQ: WGS) securities between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”).

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors it Has Filed a Complaint to Recover Losses Suffered by Purchasers of Verra Mobility Corporation Common...

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

NatureU® Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials

NatureU® Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Publish

DentaQuest Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information

Edelson Lechtzin LLP is investigating data privacy claims arising from the DentaQuest data breach.

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of MannKind’s Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and Use with...

Data at ADA 2026 Highlights Key Findings from Clinical and Real‑World Studies of Afrezza® (Inhaled Insulin) Across Pediatric Care, Pregnancy, and AID Use

Ambrosia Biosciences Announces Preclinical Data Supporting Differentiated Profile of AMB-702, its Novel Small Molecule GLP-1 Receptor Agonist Development Candidate

AMB-702 demonstrates superior target coverage and efficacy in lean non-human primates The dataset was shared as part of a poster presentation at the American Diabetes...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsAs

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers